RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 48 min ago
Mon, 07/03/2023 - 02:00
Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases 3/7/2023
Mon, 07/03/2023 - 02:00
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine 3/7/2023
Mon, 07/03/2023 - 02:00
Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor 3/7/2023
Mon, 07/03/2023 - 02:00
Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III 3/7/2023
Mon, 07/03/2023 - 02:00
Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin 3/7/2023
Sun, 06/04/2023 - 02:00
AI Therapeutics Posts First Clinical Data for New ALS Mechanism 4/6/2023
Sun, 06/04/2023 - 02:00
Hedge Fund Wages Proxy Battle with Exelixis Over R&D 4/6/2023
Sun, 06/04/2023 - 02:00
NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful 4/6/2023
Sun, 06/04/2023 - 02:00
Pfizer Publishes Phase III RSV Data Ahead of May Decision 4/6/2023
Sun, 06/04/2023 - 02:00
How the IRA Will Affect Drug Development 4/6/2023
Sat, 06/03/2023 - 02:00
FDA Sets July Decision Date for Full Approval of Leqembi 3/6/2023
Sat, 06/03/2023 - 02:00
Voyager Rolls on as Novartis Selects Two of Three CNS Targets 3/6/2023
Sat, 06/03/2023 - 02:00
Full Results from Esperion's Cholesterol Drug Fail to Impress Investors 3/6/2023
Sat, 06/03/2023 - 02:00
Incyte Abandons Phase III Trial for Myelofibrosis Treatment 3/6/2023
Sat, 06/03/2023 - 02:00
How to Nail Virtual Interviews & Networking Events 3/6/2023
Sat, 06/03/2023 - 02:00
FDA Action Alert: Roche and Acadia 3/6/2023
Wed, 05/31/2023 - 02:00
AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study 5/31/2023
Wed, 05/31/2023 - 02:00
FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial 5/31/2023
Wed, 05/31/2023 - 02:00
Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody 5/31/2023
Wed, 05/31/2023 - 02:00
Glyscend’s First-in-Class Oral Diabetes Drug Shows Phase II Promise 5/31/2023